Cost Effectiveness of Raloxifene in the Treatment of Osteoporosis in Sweden: An Economic Evaluation Based on the MORE Study

Author: Fredrik Borgström   Olof Johnell  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.22, Iss.17, 2004-01, pp. : 1153-1165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content